115 related articles for article (PubMed ID: 2002594)
1. [Myocardial fatty acid metabolic imaging using C-11 labeled palmitate].
Tamaki N; Kawamoto M; Yonekura Y; Magata Y; Konishi J
Nihon Rinsho; 1991 Jan; 49(1):148-54. PubMed ID: 2002594
[No Abstract] [Full Text] [Related]
2. [Regional assessment of myocardial fatty acid metabolism by PET with 11C-palmitate].
Tamaki N; Kawamoto M; Tadamura E; Konishi J
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):629-35. PubMed ID: 12436593
[No Abstract] [Full Text] [Related]
3. Fatty acid uptake and "metabolic imaging" of the heart.
Klein MS; Sobel BE
Cardiovasc Clin; 1979; 10(2):165-76. PubMed ID: 385142
[No Abstract] [Full Text] [Related]
4. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
Schelbert HR
Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
[No Abstract] [Full Text] [Related]
5. Positron tomography and myocardial metabolism: an overview.
Sobel BE
Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
[No Abstract] [Full Text] [Related]
6. Metabolic imaging of patients with cardiomyopathy.
Geltman EM
Circulation; 1991 Sep; 84(3 Suppl):I265-72. PubMed ID: 1884495
[TBL] [Abstract][Full Text] [Related]
7. [Fatty acid metabolism using C-11 palmitate: (1). Resting study].
Tamaki N; Yonekura Y; Magata Y; Saji H; Fujibayashi Y; Sasayama S; Yamashita K; Ohtani H; Fujita T; Yamada T
Kaku Igaku; 1990 Apr; 27(4):313-21. PubMed ID: 2376917
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of myocardial fatty acid metabolism using PET.
Bergmann SR; Weinheimer CJ; Markham J; Herrero P
J Nucl Med; 1996 Oct; 37(10):1723-30. PubMed ID: 8862319
[TBL] [Abstract][Full Text] [Related]
9. Myocardial metabolic changes in hypertrophic cardiomyopathy.
Tadamura E; Tamaki N; Matsumori A; Magata Y; Yonekura Y; Nohara R; Sasayama S; Yoshibayashi M; Kamiya T; Konishi J
J Nucl Med; 1996 Apr; 37(4):572-7. PubMed ID: 8691242
[TBL] [Abstract][Full Text] [Related]
10. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
[TBL] [Abstract][Full Text] [Related]
11. Regional assessment of myocardial metabolic integrity in vivo by positron-emission tomography with 11C-labeled palmitate.
Ter-Pogossian MM; Klein MS; Markham J; Roberts R; Sobel BE
Circulation; 1980 Feb; 61(2):242-55. PubMed ID: 6965365
[No Abstract] [Full Text] [Related]
12. Assessment of myocardial fatty acid metabolism with positron emission tomography at rest and during dobutamine infusion in patients with coronary artery disease.
Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Torizuka T; Nohara R; Kambara H; Konishi J
Am Heart J; 1993 Mar; 125(3):702-10. PubMed ID: 8438699
[TBL] [Abstract][Full Text] [Related]
13. Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy.
Sochor H; Schelbert HR; Schwaiger M; Henze E; Phelps ME
Eur J Nucl Med; 1986; 12 Suppl():S66-9. PubMed ID: 3490381
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid kinetics in aerobic myocardium: characteristics of tracer carbon entry and washout and influence of metabolic demand.
Nellis SH; Liedtke AJ; Renstrom B
J Nucl Med; 1992 Oct; 33(10):1864-74. PubMed ID: 1403160
[TBL] [Abstract][Full Text] [Related]
15. C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism.
Schelbert HR; Henze E; Schon HR; Keen R; Hansen H; Selin C; Huang SC; Barrio JR; Phelps ME
Am Heart J; 1983 Mar; 105(3):492-504. PubMed ID: 6600872
[No Abstract] [Full Text] [Related]
16. Biochemical approaches to metabolism: application to positron-emission tomography.
McMillin-Wood JB
Circulation; 1985 Nov; 72(5 Pt 2):IV145-50. PubMed ID: 2865017
[No Abstract] [Full Text] [Related]
17. I-123 heptadecanoic acid--value and limitations in comparison with C-11 palmitate.
Schön HR
Eur J Nucl Med; 1986; 12 Suppl():S16-9. PubMed ID: 3490371
[TBL] [Abstract][Full Text] [Related]
18. External assessment of myocardial metabolism with C-11 palmitate in vivo.
Goldstein RA; Klein MS; Welch MJ; Sobel BE
J Nucl Med; 1980 Apr; 21(4):342-8. PubMed ID: 6966678
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.
Tamaki N; Kawamoto M; Takahashi N; Yonekura Y; Magata Y; Nohara R; Kambara H; Kawai C; Konishi J
Ann Nucl Med; 1991 Jul; 5(2):53-8. PubMed ID: 1777350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
